Gemcitabine-Loaded Microbeads for Treating Kidney Tumors
Author Information
Author(s): Zhang Xiaoli, Li Tingting, Tong Jindong, Zhou Meihong, Wang Zi, Liu Xingdang, Lu Wei, Lou Jingjing, Yi Qingtong
Primary Institution: Fudan University Pudong Medical Center
Hypothesis
Can gemcitabine-loaded drug-eluting beads (G-DEBs) improve the treatment of renal tumors through transarterial chemoembolization (TACE)?
Conclusion
G-DEBs are effective in treating rabbit VX2 renal tumors, and 18F-FDG PET/CT is a useful method for monitoring treatment effects.
Supporting Evidence
- The average particle size of the microspheres was 58.06 ± 0.50 µm.
- The maximum loading rate of G-DEBs was 18.09 ± 0.35%, with almost 100% encapsulation efficiency.
- Compared to the untreated control group, the G-DEBs group showed significant reductions in tumor volume.
- Histopathological analysis confirmed that the proliferating area of tumor cells was significantly reduced in the G-DEBs group.
Takeaway
Researchers created special beads that release a cancer drug directly into kidney tumors, helping to shrink them and making it easier to see how well the treatment is working.
Methodology
The study involved preparing G-DEBs, implanting VX2 tumors in rabbits, and using 18F-FDG PET/CT to evaluate treatment effects after TACE.
Potential Biases
Potential bias due to small sample size and lack of long-term follow-up.
Limitations
The sample size was small, and the study did not assess long-term outcomes beyond 14 days post-treatment.
Participant Demographics
New Zealand white rabbits, 2-3 kg, 3-4 months old, male.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website